Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001553 | 56.0627 | 0.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 57.0705 | 23.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 58.0788 | 20.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 61.0894 | 22.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 61.0897 | 20.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 73.0893 | 0.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 73.0896 | 0.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 75.1050 | 23.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-THREONINE (M+H-H2O) | 85.0527 | 0.95 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 85.9687 | 22.23 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 87.1054 | 1.52 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 91.0637 | 1.32 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 91.9856 | 0.52 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 92.0629 | 20.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 94.0628 | 5.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 95.0738 | 2.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 96.0941 | 22.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 101.0834 | 2.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 101.1208 | 3.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | DELTA-VALEROLACTONE (M+H) | 102.0679 | 2.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 104.0140 | 0.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 104.0323 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 105.0615 | 0.95 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-ALPHA-AMINOBUTYRIC ACID (M+H) | 105.0781 | 0.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 105.1156 | 22.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 105.1156 | 22.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 105.1156 | 22.38 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 106.0421 | 4.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-SERINE (M+H) | 107.0576 | 0.95 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 110.1089 | 9.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 112.1251 | 8.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 112.1253 | 18.25 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 112.1255 | 21.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-GLUTAMIC ACID (M+H-H2O) | 113.0466 | 0.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | N-ACETYLSERINE (M+H-H2O) | 113.0482 | 0.91 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 114.0297 | 0.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | CREATININE (M+H) | 115.0741 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 115.0997 | 4.32 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 115.1002 | 4.52 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 115.1363 | 6.37 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | PIPERAZINE-2,5-DIONE (M+H) | 116.0585 | 0.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | L-PROLINE (M+H) | 117.0783 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 117.9948 | 22.21 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 119.0766 | 0.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 119.0944 | 0.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-VALINE (M+H) | 119.0949 | 0.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 121.0582 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 122.0590 | 5.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 122.1072 | 16.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 122.1074 | 16.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 123.0651 | 2.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 124.0525 | 1.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | NIACINAMIDE (M+H) | 124.0624 | 1.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 124.1241 | 17.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 128.0451 | 1.42 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 128.0806 | 2.37 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 128.1201 | 9.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | BENZYL METHYL SULFIDE (M+H) | 129.1152 | 8.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 130.1352 | 18.06 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | PYROGLUTAMIC ACID (M+H) | 131.0588 | 1.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | PIPECOLIC ACID (M+H) | 131.0937 | 0.9 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 131.0943 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 132.0256 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | CREATINE (M+H) | 133.0842 | 0.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | L-ISOLEUCINE (M+H) | 133.1106 | 1.56 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 134.0403 | 0.95 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 134.0876 | 3.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | ORNITHINE (M+H) | 134.1054 | 0.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 136.0121 | 0.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 137.0814 | 4.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 137.0823 | 4.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 137.0841 | 1.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | HYPOXANTHINE (M+H) | 138.0544 | 1.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 138.0546 | 1.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 2-AMINOBENZOIC ACID (M+H) | 140.0624 | 5.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 140.0694 | 5.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 140.0811 | 4.23 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 141.0760 | 0.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 142.0285 | 2.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 142.0607 | 3.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 142.0969 | 5.21 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 145.1099 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 145.1099 | 0.9 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 147.1256 | 3.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 147.1259 | 3.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | SPERMIDINE (M+H) | 147.1735 | 0.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 148.0660 | 4.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 148.0678 | 3.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-LYSINE (M+H) | 148.1214 | 0.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | EPINEPHRINE (M+H-H2O) | 149.0816 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 149.1026 | 0.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 149.1038 | 0.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 2-HYDROXYBUTYRIC ACID (M+Na) | 150.0271 | 1.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 150.0357 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 150.0665 | 18.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-METHIONINE (M+H) | 151.0670 | 0.95 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 152.0846 | 14.38 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 153.0427 | 0.91 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | GUANINE (M+H) | 153.0652 | 0.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | ACETAMINOPHEN (M+H) | 153.0791 | 3.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 154.0610 | 3.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 154.0614 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 154.1358 | 16.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 154.1364 | 19.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 155.0561 | 1.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 156.0787 | 5.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | DIAMINOPIMELIC ACID (M+H-H2O) | 156.0877 | 0.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 156.1511 | 18.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-HISTIDINE (M+H) | 157.0839 | 0.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 157.1187 | 5.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 158.0920 | 3.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 158.0920 | 3.91 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 158.0921 | 3.81 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 159.1248 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 159.1255 | 4.4 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 159.1256 | 0.92 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 159.1625 | 15.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 159.9729 | 0.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 160.0360 | 0.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 160.0726 | 8.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 160.1001 | 3.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 161.0416 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-PROLINE (M+Na) | 161.0418 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | INDOLEACETALDEHYDE (M+H) | 161.0845 | 1.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 161.1412 | 0.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 161.1420 | 6.37 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 162.0513 | 5.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | TRANS-CYCLOHEXANE-1,2-DIOL (M+Na) | 162.0634 | 3.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 162.0937 | 3.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-VALINE (M+Na) | 163.0582 | 0.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 163.0584 | 0.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 163.0590 | 0.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 163.0672 | 1.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-CARNITINE (M+H) | 163.1202 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 2-HYDROXY-3-METHYLBUTYRIC ACID (M+Na) | 164.0428 | 3.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 164.0479 | 11.25 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 164.0800 | 4.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 5-HYDROXYLYSINE (M+H) | 164.1170 | 0.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 164.1414 | 10.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 164.1558 | 23.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 165.0645 | 1.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 166.0632 | 1.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 167.0628 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-PHENYLALANINE (M+H) | 167.0939 | 2.42 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 167.0952 | 12.14 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 1-METHYLXANTHINE (M+H) | 168.0655 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 168.0800 | 17.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 168.1121 | 9.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 168.1146 | 16.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 168.1146 | 16.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 168.1152 | 22.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 170.0270 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 170.0273 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 170.0444 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | URIC ACID (M+H) | 170.0446 | 0.99 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | HOMOGENTISIC ACID (M+H) | 170.0557 | 2.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 170.1031 | 2.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 170.1277 | 8.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 170.1282 | 14.4 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 171.1262 | 7.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 172.1076 | 6.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 172.1102 | 10.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 172.1465 | 16.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | BENZYL METHYL SULFIDE (M+Na) | 173.0800 | 8.02 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 173.1781 | 17.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | KETO-PANTOYLLACTONE (M+Na) | 174.0280 | 3.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 174.0868 | 2.25 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 175.0612 | 3.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | QUINOLINE-4-CARBOXYLIC ACID (M+H) | 175.0633 | 5.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 175.1298 | 5.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 176.0419 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 176.0422 | 4.42 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | KETOLEUCINE (M+Na) | 176.0430 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 176.0450 | 7.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 176.1171 | 1.4 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-ARGININE (M+H) | 176.1266 | 0.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | L-ISOLEUCINE (M+Na) | 177.0743 | 1.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 177.0744 | 1.51 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 177.0795 | 8.56 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 178.0639 | 15.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | SEROTONIN (M+H) | 178.1107 | 1.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 180.0766 | 2.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | HIPPURIC ACID (M+H) | 181.0749 | 4.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 181.1447 | 15.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | HYPOXANTHINE (M+Na) | 182.0181 | 1.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | THEOBROMINE (M+H) | 182.0813 | 3.51 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | THEOPHYLLINE (M+H) | 182.0813 | 4.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 182.0822 | 4.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 182.0920 | 4.12 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 182.0932 | 9.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 182.0947 | 15.81 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 182.1658 | 23.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-TYROSINE (M+H) | 183.0903 | 1.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 183.1260 | 14.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 184.0733 | 6.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 184.0799 | 15.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 184.1074 | 4.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 184.1081 | 11.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 184.1441 | 13.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 184.1803 | 20.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | PHOSPHORYLCHOLINE (M+H) | 185.0834 | 0.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 186.1054 | 15.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 186.1237 | 10.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 186.1259 | 13.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 186.1372 | 3.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 187.1202 | 0.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 187.2301 | 17.27 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 188.0373 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-CYSTATHIONINE (M+H-H2O) | 188.0598 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 189.0436 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 189.1008 | 5.12 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 189.1369 | 7.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 190.0161 | 1.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 190.0161 | 1.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 190.0320 | 10.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 190.0613 | 7.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 190.0788 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | N6,N6,N6-TRIMETHYL-L-LYSINE (M+H) | 190.1680 | 0.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 191.0952 | 10.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 192.0261 | 0.99 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-GLUTAMINE (M+Na) | 192.0478 | 0.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | L-LYSINE (M+Na) | 192.0851 | 0.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 192.1728 | 14.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 192.1873 | 19.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 192.1878 | 19.09 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 193.0409 | 0.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 193.0739 | 2.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 193.1140 | 5.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | CITRAMALIC ACID (M+Na) | 194.0173 | 1.37 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 194.0279 | 0.95 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 195.1252 | 0.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | CAPRIC ACID (2M+Na) | 195.1359 | 22.74 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | D-RIBOSE (M+Na) | 196.0316 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 196.0734 | 8.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 196.0769 | 11.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | CAFFEINE (M+H) | 196.0987 | 5.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 196.1110 | 17.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 196.1220 | 4.19 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 196.1300 | 3.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 196.1447 | 18.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 196.1462 | 18.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | ACETAMINOPHEN (M+Na) | 197.0430 | 3.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 197.1124 | 5.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.0885 | 8.4 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.0891 | 5.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.0947 | 18.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.0976 | 1.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.1233 | 14.4 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.1236 | 6.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.1363 | 3.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.1364 | 3.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 198.1380 | 5.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 199.0530 | 4.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 199.0618 | 8.56 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 200.1381 | 9.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 200.1778 | 18.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 200.1780 | 22.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 200.1783 | 21.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 201.2096 | 20.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 202.0526 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 202.0534 | 11.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 202.0540 | 3.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 202.0976 | 12.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 202.0979 | 15.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 202.1172 | 5.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | D-GLUCOSE (2M+Na) | 203.0536 | 0.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 203.1530 | 10.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 204.0356 | 3.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 204.1475 | 2.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | SPERMINE (M+H) | 204.2317 | 0.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 205.1142 | 9.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 205.1312 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-ACETYLCARNITINE (M+H) | 205.1317 | 0.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 205.9898 | 1.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 206.0634 | 16.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 206.0634 | 16.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 206.0704 | 10.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 206.0950 | 20.78 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 206.0951 | 20.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-TRYPTOPHAN (M+H) | 206.1066 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 207.0903 | 7.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 208.0416 | 8.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 208.0706 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-TRYPTOPHAN-15N2 (M+H) | 208.1011 | 3.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 208.1191 | 3.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 208.1443 | 18.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 208.1823 | 21.42 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 208.1826 | 22.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 209.1416 | 3.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 2-DEOXYGLUCOSE (M+Na) | 210.0477 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 210.0899 | 7.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 210.0956 | 18.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-KYNURENINE (M+H) | 210.1012 | 2.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 210.1245 | 15.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 210.1262 | 18.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 210.1976 | 19.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 210.1978 | 19.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-PHENYLALANINE (M+Na) | 211.0578 | 2.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 211.1192 | 7.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 1-METHYLXANTHINE (M+Na) | 212.0288 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 212.0691 | 4.35 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.0973 | 2.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1033 | 8.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1034 | 8.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1040 | 10.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1047 | 11.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1073 | 11.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1101 | 19.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1154 | 2.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1183 | 20.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1390 | 9.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1395 | 16.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 212.1763 | 23.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 213.0291 | 13.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 213.0776 | 10.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 213.0780 | 11.81 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 3-METHOXYTYROSINE (M+H) | 213.1004 | 2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 214.0838 | 7.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 214.0915 | 14.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 214.1555 | 14.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 214.1563 | 16.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 215.0244 | 13.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 215.0986 | 13.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 215.1873 | 14.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.0250 | 0.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.0322 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.0326 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.0368 | 1.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.0685 | 21.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.1045 | 3.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.1049 | 15.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.1050 | 16.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.1133 | 18.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.1341 | 7.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.1343 | 7.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 216.1732 | 18.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 217.0632 | 1.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 217.0759 | 6.95 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 217.1682 | 12.38 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 217.2044 | 14.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0261 | 3.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0271 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0485 | 6.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0485 | 6.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0503 | 5.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0567 | 11.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0572 | 10.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.0948 | 17.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.1053 | 4.19 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.1136 | 3.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.1267 | 18.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 218.1643 | 20.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 219.0225 | 4.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | N-ACETYLLEUCINE (M+Na) | 219.0853 | 7.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 219.1375 | 3.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | PROPIONYLCARNITINE (M+H) | 219.1478 | 1.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 220.0056 | 3.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 220.0276 | 0.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 220.0590 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 220.0634 | 3.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 220.0839 | 2.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-ARGININE (M+Na) | 220.0909 | 0.56 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 220.1208 | 5.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 220.1755 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 220.1827 | 19.92 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 220.1830 | 21.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 221.1086 | 2.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | PANTOTHENIC ACID (M+H) | 221.1276 | 3.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | CIS-ZEATIN (M+H) | 221.1291 | 3.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 221.1578 | 22.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 222.0218 | 8.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 222.0342 | 16.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 222.0350 | 16.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 222.0889 | 9.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 5-HYDROXY-L-TRYPTOPHAN (M+H) | 222.1004 | 1.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 222.1334 | 2.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 222.1402 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 222.1598 | 19.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 223.1705 | 22.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 223.1916 | 20.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 224.0229 | 5.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-CYSTATHIONINE (M+H) | 224.0831 | 0.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 224.1067 | 15.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 224.1069 | 15.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 224.1077 | 15.25 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 224.1120 | 19.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 224.1163 | 3.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 224.2119 | 19.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | HIPPURIC ACID (M+Na) | 225.0385 | 4.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 225.1350 | 10.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | METHIONINE SULFOXIMINE (M+Na) | 226.0379 | 0.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | D-GLUCOSE (M+Na) | 226.0433 | 0.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | THEOPHYLLINE (M+Na) | 226.0443 | 4.35 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 226.1205 | 13.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 226.1207 | 13.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 226.1557 | 18.21 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 226.1564 | 17.12 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 226.1574 | 18.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 227.0255 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 227.0256 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-TYROSINE (M+Na) | 227.0539 | 1.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 227.0859 | 7.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 227.1891 | 15.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 227.9611 | 0.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 227.9820 | 5.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | HYDROXYPHENYLLACTIC ACID (M+Na) | 228.0372 | 3.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 228.0706 | 14.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 228.0710 | 10.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | CARNOSINE (M+H) | 228.1214 | 0.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 228.1344 | 11.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 229.0490 | 10.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 229.0724 | 4.99 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 229.0725 | 7.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 229.2050 | 16.23 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 229.2053 | 22.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 229.2411 | 21.9 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 229.9649 | 0.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.0577 | 11.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.0833 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.0845 | 9.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.0848 | 16.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.0851 | 16.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.1208 | 18.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.1322 | 0.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.1499 | 11.14 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 230.9850 | 1.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 231.1840 | 14.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 231.2569 | 17.09 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 231.2572 | 17.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.0051 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.0053 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.0271 | 2.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.0726 | 13.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.0791 | 16.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.0928 | 3.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.1107 | 15.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.1290 | 5.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.1357 | 0.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.1787 | 4.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 232.1791 | 3.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 233.1191 | 5.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 233.1376 | 1.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | O-ISOBUTYRYL-L-CARNITINE (M+H) | 233.1634 | 2.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | BUTYRYLCARNITINE (M+H) | 233.1636 | 2.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 234.0003 | 5.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.0874 | 10.25 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.0881 | 10.73 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.0902 | 11.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.0954 | 18.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.0981 | 2.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.1023 | 13.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | N6,N6,N6-TRIMETHYL-L-LYSINE (M+Na) | 234.1317 | 0.56 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 234.1344 | 7.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.1601 | 18.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 234.1979 | 21.42 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 235.0106 | 13.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 235.0875 | 0.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 235.9993 | 0.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 236.0582 | 2.25 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 236.1107 | 20.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 236.1393 | 13.81 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 236.1429 | 16.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 236.1775 | 19.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 5-HYDROXYINDOLEACETIC ACID (M+Na) | 237.0408 | 4.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 237.0810 | 13.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 237.1360 | 4.19 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.0027 | 0.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.0172 | 7.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.0902 | 16.27 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.0908 | 16.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.0910 | 16.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1194 | 11.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1196 | 9.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1203 | 9.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1219 | 13.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1274 | 21.14 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1363 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1559 | 18.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.1567 | 18.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 238.2285 | 22.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 239.1867 | 14.78 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | METHYL BETA-D-GLUCOPYRANOSIDE (M+Na) | 240.0585 | 0.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | CAFFEINE (M+Na) | 240.0627 | 5.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 240.1027 | 10.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1418 | 21.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1493 | 6.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1519 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1561 | 4.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1711 | 19.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1712 | 18.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1712 | 18.19 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 240.1736 | 21.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 241.0772 | 2.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 241.1086 | 2.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 241.1096 | 22.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-CYSTINE (M+H) | 242.0390 | 0.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 242.0780 | 8.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 242.0933 | 0.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 242.1220 | 19.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 242.1223 | 18.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 242.1497 | 14.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 242.1666 | 9.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 242.1848 | 15.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 242.1868 | 19.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 243.1105 | 3.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 243.9347 | 0.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 244.0624 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 244.0930 | 1.33 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 244.1007 | 18.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 244.1368 | 19.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 244.1430 | 6.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 244.2025 | 20.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.1380 | 3.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.1382 | 3.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.1634 | 4.06 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.2000 | 15.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.2010 | 22.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.2354 | 18.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.2721 | 17.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.2721 | 18.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.9887 | 3.09 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 245.9934 | 5.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.0802 | 11.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | URIDINE (M+H) | 246.0864 | 1.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 246.0884 | 14.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.0885 | 14.73 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.0897 | 14.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.0942 | 18.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.1080 | 4.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.1458 | 6.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.1586 | 21.78 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.1930 | 0.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.1952 | 6.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.1959 | 6.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 246.2348 | 22.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 247.1353 | 6.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 247.1616 | 16.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | ISOVALERYLCARNITINE (M+H) | 247.1786 | 4.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 247.1791 | 4.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.0584 | 1.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.0584 | 1.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.0948 | 10.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.1049 | 2.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.1053 | 14.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.1373 | 3.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.1410 | 14.38 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.1535 | 4.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 248.2343 | 21.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 249.0440 | 4.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 249.9865 | 0.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.0618 | 1.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.0620 | 1.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.0697 | 18.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-TRYPTOPHAN (M+Na) | 250.0705 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 250.1220 | 13.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.1568 | 17.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.1671 | 4.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.1888 | 17.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.1904 | 21.27 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.1916 | 19.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.1921 | 19.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 250.1935 | 20.9 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 251.0146 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 251.0476 | 4.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 251.1871 | 16.23 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 251.1977 | 22.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 251.2229 | 21.92 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 251.9830 | 0.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.0324 | 7.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.0575 | 22.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.0691 | 15.74 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.0692 | 16.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.0701 | 16.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | IBUPROFEN (M+Na) | 252.1116 | 18.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 252.1362 | 14.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.1382 | 18.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.1383 | 12.78 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.1442 | 21.74 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.2095 | 22.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 252.9736 | 3.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 253.9972 | 0.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 253.9974 | 1.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.0637 | 16.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-KYNURENINE (M+Na) | 254.0638 | 2.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 254.0643 | 16.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.0868 | 17.12 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.0936 | 16.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.1159 | 11.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.1274 | 2.11 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.1514 | 16.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.1885 | 20.92 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.2012 | 15.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 254.2219 | 22.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 255.0694 | 6.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 255.1016 | 5.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 255.1345 | 0.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 255.1553 | 0.96 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.1035 | 18.75 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.1164 | 21.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.1355 | 6.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.1391 | 19.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.1657 | 3.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.1674 | 15.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.2029 | 20.36 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.2164 | 16.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | EPIANDROSTERONE (M+H-H2O) | 256.2184 | 18.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 256.2395 | 21.51 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.2396 | 22.32 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 256.2400 | 22.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 257.2734 | 22.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 258.1171 | 19.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 258.1592 | 19.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 258.2348 | 21.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 258.2545 | 22.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | GLYCEROPHOSPHOCHOLINE (M+H) | 259.1176 | 0.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 259.2876 | 19.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 260.0081 | 5.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 260.0957 | 5.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 260.1051 | 17.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 260.1102 | 19.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 260.1243 | 6.73 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 260.1244 | 6.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 260.1244 | 6.92 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | HEXANOYLCARNITINE (M-e) | 260.1872 | 7.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 261.0327 | 8.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.0042 | 0.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.0230 | 3.51 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.0538 | 20.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.0542 | 11.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.0627 | 15.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.1121 | 3.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.1207 | 14.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.1405 | 4.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.1524 | 4.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.1527 | 4.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.1546 | 21.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.1561 | 19.21 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.2256 | 22.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 262.2481 | 21.92 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 263.1372 | 0.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 263.1379 | 0.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 263.1736 | 1.96 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.0024 | 0.59 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.0339 | 1.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.0982 | 15.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.1257 | 5.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.1352 | 17.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.1382 | 21.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.1422 | 21.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.1479 | 6.19 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.1738 | 19.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.2088 | 20.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.2427 | 21.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.2449 | 22.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 264.2463 | 23.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | PANTOTHENIC ACID (M+Na) | 265.0912 | 3.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | SPHINGOSINE (M+H-H2O) | 265.2766 | 20.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 266.0340 | 3.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.0708 | 0.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.0799 | 11.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1290 | 5.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1316 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1526 | 14.38 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1530 | 16.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1576 | 22.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1626 | 5.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1883 | 20.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.1887 | 21.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.2596 | 22.91 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.9869 | 2.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 266.9906 | 7.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 267.1821 | 15.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 267.1827 | 22.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.0275 | 3.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.0424 | 16.27 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-CYSTATHIONINE (M+Na) | 268.0473 | 0.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 268.0677 | 0.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.1469 | 6.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.1475 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.1700 | 18.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.1733 | 22.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.1831 | 20.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.2036 | 21.52 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.2404 | 22.2 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | MONOMYRISTIN (M+H-H2O) | 268.2412 | 22.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 268.2763 | 22.91 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 268.9886 | 7.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 269.0086 | 5.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 269.1175 | 6.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.0651 | 15.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | INOSINE (M+H) | 270.0988 | 1.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 270.1181 | 19.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.1190 | 16.21 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | METHYL JASMONATE (M+Na) | 270.1224 | 16.12 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 270.1351 | 4.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.1506 | 18.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.1537 | 21.33 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2179 | 21.23 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2182 | 21.37 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2193 | 21.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2364 | 22.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2372 | 23.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2549 | 22.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2556 | 22.25 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 270.2560 | 22.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 271.0716 | 15.74 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 271.9690 | 0.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.0986 | 15.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.1016 | 2.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.1692 | 21.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.1728 | 10.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.1759 | 20.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.2140 | 11.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.2149 | 15.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.2503 | 20.56 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 272.2724 | 23.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 273.1700 | 2.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 273.1944 | 7.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 273.2662 | 18.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 273.2670 | 17.32 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 273.9538 | 0.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 273.9658 | 0.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | DEOXYURIDINE (M+Na) | 274.0538 | 1.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 274.0753 | 8.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.0788 | 1.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.1117 | 16.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.1124 | 17.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.1189 | 12.75 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.1216 | 18.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.1757 | 10.74 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.1893 | 22.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 274.2306 | 14.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 275.1045 | 1.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 275.1514 | 21.14 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 275.1928 | 15.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 275.1929 | 15.78 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 275.2828 | 17.22 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 275.2835 | 16.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 275.9808 | 5.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 276.0897 | 3.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 276.1189 | 4.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 276.1347 | 16.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 276.1474 | 5.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 276.1509 | 6.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 276.1564 | 6.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 277.0049 | 8.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 277.0513 | 6.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 277.1268 | 0.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 277.1361 | 9.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | GLUTARYLCARNITINE (M+H) | 277.1539 | 1.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 277.2086 | 16.9 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 278.1510 | 15.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 278.1540 | 17.96 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 278.1872 | 17.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 278.1907 | 20.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 278.1918 | 19.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 279.0494 | 6.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 279.1317 | 0.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 279.1321 | 0.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.0284 | 11.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.0505 | 5.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.0648 | 17.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.0664 | 15.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.0852 | 3.58 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.0946 | 10.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.1100 | 2.36 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.1695 | 20.78 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.1696 | 20.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.1802 | 7.81 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.2415 | 22.92 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 280.2440 | 22.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 281.0003 | 4.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 281.1000 | 0.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 281.1483 | 0.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 281.1489 | 0.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 281.2725 | 21.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 281.2729 | 22.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.0826 | 1.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.1157 | 7.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.1177 | 20.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.1209 | 16.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.1228 | 3.96 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.1833 | 18.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.1841 | 19.23 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.2481 | 22.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.2571 | 22.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.2572 | 22.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.2576 | 23.12 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 282.2784 | 20.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 1-METHYLADENOSINE (M+H) | 283.1291 | 3.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 283.2135 | 16.22 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | OLEAMIDE (M+H) | 283.2892 | 22.6 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 284.0173 | 7.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.1338 | 21.33 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.1410 | 7.51 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.1422 | 6.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.1430 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.1499 | 22.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.1836 | 6.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.2418 | 21.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.2511 | 17.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.2712 | 22.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.2728 | 22.91 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 284.9998 | 3.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 285.0830 | 16.41 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 285.0839 | 16.32 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | GUANOSINE (M+H) | 285.1077 | 1.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 285.3045 | 22.84 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-CYSTINE (M+Na) | 286.0006 | 0.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 286.0155 | 7.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.0212 | 9.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1097 | 4.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1344 | 23.27 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1469 | 22.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1475 | 21.78 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1568 | 9.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1574 | 6.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1582 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 286.1875 | 1.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | (2E)-OCTENOYLCARNITINE (M-e) | 286.2033 | 9.52 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 286.2318 | 22.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 287.1535 | 17.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 287.2108 | 10.3 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 287.2109 | 9.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 288.1109 | 5.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 288.1354 | 14.38 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 288.1414 | 21.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 288.2074 | 13.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 288.2304 | 21.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 288.2449 | 22.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | L-OCTANOYLCARNITINE (M+H) | 289.2268 | 11.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 289.2623 | 20.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 289.2625 | 19.85 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 289.2956 | 17.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | URIDINE (M+Na) | 290.0499 | 1.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 290.0531 | 1.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.0594 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.0855 | 16.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.1356 | 6.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.1418 | 21.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.1514 | 17.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.1596 | 1.73 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.1596 | 10.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.1640 | 20.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 290.1710 | 8.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 291.0211 | 10.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 291.0433 | 7.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 291.1282 | 19.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 291.1517 | 12.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 291.1620 | 10.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 291.2782 | 17.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.0273 | 5.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.0367 | 9.06 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.0546 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.1112 | 8.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.1304 | 18.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.1611 | 5.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.1757 | 22.32 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.2423 | 22.74 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 292.2610 | 21.05 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 293.0244 | 6.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.0643 | 1.47 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.0644 | 1.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.1271 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.1559 | 10.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.1893 | 22.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.1955 | 15.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.2190 | 21.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.2540 | 23.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 294.2558 | 22.96 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 295.1110 | 1.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 295.1541 | 2.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 295.1650 | 1.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 295.9485 | 0.52 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.0001 | 11.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.0363 | 17.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.0755 | 0.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.0761 | 1.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.1384 | 5.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.2053 | 22.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.2321 | 21.69 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.2326 | 21.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.2347 | 21.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 296.2732 | 23.15 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 297.0799 | 8.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 297.2429 | 22.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 297.2662 | 17.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 297.2677 | 21.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.0239 | 0.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.1381 | 5.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.1470 | 7.14 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.1512 | 19.27 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.1571 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.2824 | 23.12 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.2846 | 22.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 298.2882 | 23.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 299.0914 | 2.54 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 5'-METHYLTHIOADENOSINE (M+H) | 299.1073 | 4.5 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 299.2825 | 19.33 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 299.2825 | 19.55 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 299.2826 | 21.72 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.0900 | 4.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.0900 | 4.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.1494 | 16.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.1495 | 13.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.1496 | 23.26 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.1720 | 19.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.1732 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.2669 | 22.65 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.2670 | 22.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 300.2670 | 22.75 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 301.2086 | 17.1 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 301.2260 | 11.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 301.2940 | 22.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | SPHINGOSINE (M+H) | 301.2991 | 20.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 302.0854 | 15.87 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1154 | 6.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1158 | 5.91 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1284 | 12.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1426 | 18.16 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1513 | 20.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1513 | 20.86 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1535 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1552 | 20.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.1869 | 19.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.2216 | 22.75 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.2235 | 22.52 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.2623 | 17.66 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 302.2941 | 17.4 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.1301 | 0.68 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.1304 | 0.93 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.2055 | 3.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.2244 | 18.21 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.2408 | 13.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.2414 | 13.17 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.2415 | 12.77 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 303.2554 | 22.34 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | SPHINGANINE (M+H) | 303.3121 | 20.67 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 304.0321 | 9.06 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.0441 | 15.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.1083 | 14.38 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.1509 | 8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.1543 | 1.82 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.1686 | 9.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.1858 | 9.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.2034 | 20.43 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.2378 | 22.35 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.2386 | 22.48 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 304.2408 | 21.9 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 305.2397 | 18.98 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 305.2924 | 18.32 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 305.3083 | 18.44 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 306.0318 | 3.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 306.0926 | 5.29 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 306.1466 | 20.31 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 306.1664 | 5.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 306.1677 | 6.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 306.2564 | 22.33 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | CYTIDINE 2',3'-CYCLIC PHOSPHATE (M+H) | 307.0554 | 0.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 308.0279 | 3.63 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.0590 | 15.03 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.0597 | 14.97 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.0978 | 18.79 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.1965 | 17.64 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.1979 | 20.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.2060 | 22.81 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.2071 | 22.9 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 308.2539 | 22.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 309.1362 | 17.89 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 309.2385 | 22.49 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | DUMP (M+H) | 310.0593 | 0.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 310.1220 | 0.61 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 310.1624 | 22.57 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 310.1912 | 13.04 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 310.2141 | 21.56 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 310.2154 | 21.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 310.2211 | 23.01 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 310.2500 | 22.39 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | N-ACETYLNEURAMINIC ACID (M+H) | 311.1212 | 0.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001553 | 311.1382 | 2.88 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 311.2106 | 11.76 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 311.2108 | 11.46 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 311.2109 | 10.7 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 311.2109 | 10.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 311.2439 | 20.23 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.0765 | 0.94 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.0926 | 15.8 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1375 | 4.53 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1378 | 6.71 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1380 | 8.62 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1401 | 7.51 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1622 | 24.24 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1626 | 22.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1654 | 19.08 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.1788 | 22.83 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.2055 | 21.45 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.2135 | 9.13 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.2469 | 23.07 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 312.2642 | 22.28 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001553 | 313.1206 | 1.18 | Minutes | ST000946 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
